WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitors (Q39430425)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitors |
scientific article |
Statements
1 reference
WZ4002, a third-generation EGFR inhibitor, can overcome anoikis resistance in EGFR-mutant lung adenocarcinomas more efficiently than Src inhibitors (English)
1 reference
Yuji Sakuma
1 reference
Yukiko Yamazaki
1 reference
Yoshiyasu Nakamura
1 reference
Mitsuyo Yoshihara
1 reference
Shoichi Matsukuma
1 reference
Haruhiko Nakayama
1 reference
Tomoyuki Yokose
1 reference
Yoichi Kameda
1 reference
Shiro Koizume
1 reference
Yohei Miyagi
1 reference
12 December 2011
1 reference
1 reference
92
1 reference
3
1 reference
371-383
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference